Latest From Biotech Now

Biotech should embrace open, online communication

Conversations

At the upcoming 2011 BIO International Convention, we will issue a new opinion survey measuring public attitudes toward our industry and where government support for our industry ranks among other national priorities.  While the survey found some interesting new data – sorry, you’ll have to wait until next week to get the details – we saw some results that are nearly the same each year we field this survey.  We found that voters’ image of Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

House Patent Reform Bill, HR 1249, still has the Administration’s and BIO’s support

patent reform june 22 2011

The White House, Office of Management and Budget, Office of Science and Technology Policy, and the United States Patent and Trademark Office have come out in support of HR 1249 and the Manager’s Amendment to the bill.  The only caveat mentioned is that “final legislative action [should] ensure that the US Patent and Trademark Office’s (USPTO’s) fee collections are made fully available to support the nation’s patent and trademark system.” BIO also has come out in Read More >

Patently BIOtech  |  3 Comments  |  Email This Post
Tags: , , , , , ,

BIO, Here We Come!

Angie Drakulich from PharmaTech Talk writes: Next week is the annual Biotechnology Industry Organization (BIO) Convention in Washington, DC. Many of our editorial team members will be there and we hope to see you. With a regulatory pathway for biosimilars underway in the United States, renewed conversations about regenerative medicine, and a booming biotech sector, the convention should be quite dynamic. Angie is part of our BIO Official Blog Program. Keep an eye on her Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Official Bloggers Program: Focus on Biosimilars

Andrew Williams wrote a second part to his original blog entry on 2011 BIO International Convention preview… This time his focus is on Biosimilars: For BIO attendees interested in learning more about the relatively new pathway for FDA approval of biosimilars, also known as follow-on biologics, there are several sessions devoted to the intricacies of the new law, or how the new legislation is impacting the BIO community.  The biosimilar framework was introduced last year Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIOtechNOW: Where the biotech industry meets online

JimGreenwood

As the biotech industry prepares to meet at the 2011 BIO International Convention in Washington, DC next week, I’m pleased to announce that we’ve re-launched BIOtechNOW as a multi-blog platform. Our new platform aims to create an online biotech community where we can connect to discuss the latest industry news – kind of like our convention, but available online 365 days a year. BIOtechNOW will be a critical component of our advocacy, education and business Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,